The upregulation of ADAMTS9-AS2 suppresses GC advancement and enhances the sensitivity of cisplatin-resistant GC cells to cisplatin by mediating the miR-223-3p/NLRP3 axis, thereby inducing pyroptosis (149). The gene discussed is NLRP3; the disease is gastric cancer.